Shortly following excellent interim Rett trial results, you could see BTD - off to the races as that point.
Very well said! The potential is simply staggering.
What is equally baffling as the potential is staggering, is that AVXL continues to generate so little interest among Wall Street's Heavy Hitters. Since I am certain Wall Street, the Institutions, and Big Pharma aren't totally unaware, then I am left to conclude they simply are not yet convinced. Considering the past abysmal P3 trial results of pretty much all proposed Alzheimer's treatments, one can understand the reluctance to rush in here. Okay though, as we retail can benefit from the current relatively low AVXL market cap - well, as long as one has dry powder with which to capitalize on the opportunity; the waiting is a killer though.
Sentiment: Strong Buy
Quite a change from just a week or two ago.
Big jump - approaching recent high of 142%
*Note that I.B. has in the past routinely charged a hefty premium over say Fidelity, but generally when I.B. cost increases so also has Fidelity/Schwab.
I think Shorty has lost his nerve. Bet the sissies don't get any of the dilution. And they still have 100M shares to cover.
Are the negative postings anything like the filth we longs constantly have to delete/ignore from the Yahoo board? Or are they civil posts which simply blast Matt for deceiving us all once again - that type of stuff?
Yep, no mercy on the street. Either Matt delivers those international partners or MNKD is finished.
Looks like they loaned out all 550,000 shares they did have available by market open.
One could presume Matt knew there was no international deal with sig. upfront cash on the last call - he will be lucky if he isn't sued for intimating that dilution wasn't a likelihood.
Yep, once again he thought he had something but Geeee it just didn't quite come in once again.
I have lost faith in Mathew Pfeffer, at least for now. If there were serious international interest Matt should have delivered a deal or two by now. Maybe Matt just can't close a deal. This was the last straw for me. Selling all but my 2018 calls
Will be back if the share price drops low enough to take a another stake.
Honestly, considering the repeatedly positive preliminary and anecdotal reports, am surprised there is so little inst. accumulation going on here. Oh well, guess it will take further positive indications confirming A2-73 is the real deal to convince WS.
Sentiment: Strong Buy
Looks to be no real shortage of shares available for borrow of late ; (